CIK 0001205922 · Non-accelerated filer<br>Smaller reporting company
VACCINEX, INC.
Sign in to watch- Ticker
- VCNX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161603202
- Phone
- 585-271-2700
- Business address
- 1895 MOUNT HOPE AVE, ROCHESTER, NY, 14620
- Former names
- VACCINEX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 54 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-23 | FRIEDBERG ALBERT Director | Grant or award | +3,778,575 | $0.53 | $2.0M | 15,359,011 |
| 2022-11-23 | Zauderer Maurice President and CEO | Grant or award | +1,511,430 | $0.53 | $800K | 4,410,984 |
| 2022-11-23 | Frieberg Jacob B. Director | Grant or award | +188,928 | $0.53 | $100K | 193,049 |
| 2022-11-23 | Van Strydonck, Gerald E. Director | Grant or award | +47,232 | $0.53 | $25K | 67,232 |
| 2022-09-30 | Frieberg Jacob B. Director | Grant or award · Stock Option (Right to Buy) | +26,260 | 26,260 | ||
| 2022-06-30 | Frieberg Jacob B. Director | Grant or award · Stock Option (Right to Buy) | +12,064 | 12,064 | ||
| 2022-05-12 | Stecyk Chrystyna Bedrij Director | Grant or award · Stock Option (Right to Buy) | +53,254 | 53,254 | ||
| 2022-05-12 | Van Strydonck, Gerald E. Director | Grant or award · Stock Option (Right to Buy) | +53,254 | 53,254 | ||
| 2022-05-12 | MANIAN BALA S Director | Grant or award · Stock Option (Right to Buy) | +53,254 | 53,254 | ||
| 2022-05-12 | Yanni Barbara Director | Grant or award · Stock Option (Right to Buy) | +53,254 | 53,254 | ||
| 2022-05-12 | Frieberg Jacob B. Director | Grant or award · Stock Option (Right to Buy) | +53,254 | 53,254 | ||
| 2022-04-01 | Smith Ernest S. SVP, Research & CSO | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2022-04-01 | Leonard John E. SVP, Development | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2022-04-01 | Zauderer Maurice President and CEO | Grant or award · Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2022-04-01 | Evans Elizabeth E. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2022-04-01 | Royer Scott E. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2022-03-31 | Frieberg Jacob B. Director | Grant or award · Stock Option (Right to Buy) | +10,032 | 10,032 | ||
| 2022-02-23 | Van Strydonck, Gerald E. Director | Purchase | +2,000 | $1.30 | $3K | 2,000 |
| 2022-02-23 | Van Strydonck, Gerald E. Director | Purchase | +18,000 | $1.32 | $24K | 20,000 |
| 2022-01-27 | Frieberg Jacob B. Director | Purchase | +90,090 | $1.11 | $100K | 94,510 |
Page 5 of 8 · 146 trades